Cardiopulmonary bypass may result in renal impairment but there is little investigative data on the effect of differing flowrates on postoperative renal function. One hundred and twenty-two patients presenting for cardiac surgery were randomly assigned to receive either a fixed CPB flow of 2.4 l.m -2 or a bypass flow tailored to maintain a venous return oxygen saturation of 75-80%. Vasoactive drugs were given to maintain a per fusion pressure of 50 to 80 mmHg. Patients were assessed by serum creatinine, creatinine clearance, arterial blood gases, serum lactates and electrolytes. The results show an overall decline in postoperative renal function compared with preoperative levels, with no significant differences between the two groups.
Postoperative renal impairment is a frequent complication of coronary artery bypass surgery and established renal failure is associated with a high mortality. I The effect of differing methods of management of cardiopulmonary bypass (CPB) on postoperative renal function has been little studied. Each institution providing a CPB service will have its own preferred method of management. In particular the flowrates used during CPB may vary widely. Some perfusionists prefer to use relatively high flows, commonly about 2.4 l.min -I.m -2 which is the accepted cardiac index of resting man at 37°C. However, as metabolic demands of the body fall with the hypothermia used, other perfusionists will markedly decrease bypass flowrates. As bypass flows decrease perfusion pressures also fall and there is evidence to show that low perfusion pressures are associated with poor cerebral and renal outcomes. ' .J Vasoconstrictors are often used to maintain perfusion pressure during CPB, but their use may impair renal function.
The aim of our trial was to prospectively compare renal function in one group of patients receiving a fixed CPB flowrate of 2.4 l.min -1 .m -2 with a group whose CPB flowrate was tailored to maintain a mixed venous return oxygen saturation of 75fJ!o with perfusion pressures maintained between 50 and 80 mmHg.
METHOD
After gaining hospital Ethical Committee approval and written informed consent, 122 adult patients presenting for coronary artery bypass grafting for the first time were randomly allocated to receive either a fixed or tailored flow type of CPB.
A. Anaesthetic and CPB management
All patients received the following standardised anaesthetic and CPB management which is routine at our institution. Premedication consisted of oral lorazepam 2-4 mg two hours preoperatively and intramuscular morphine 5-15 mg and droperidol 2.5-5 mg one hour preoperatively. At induction the patients were given fentanyl 20 /Lg.kg -I and thiopentone 0.5-1 mg.kg I as necessary and pancuronium 0.1 mg.kg -I. Patients were ventilated with oxygen, nitrous oxide and enflurane before tracheal intubation. Prior to commencing CPB the patients were ventilated using intermittent positive pressure ventilation, keeping the end-tidal carbon dioxide tension at 35-40 mmHg. Ringer's solution (500-1000 ml) was given as necessary before CPB. Dopamine (2/Lg.kg 1 .min -I) was given throughout, including when on bypass. Glyceryl trinitrate infusions (2/Lg.kg -I .min -I) were given to all patients before and after CPB. Non-pulsatile bypass flow with Cobe CML membrane oxygenators and 20 micron arterial line filters were used. Whilst on CPB anaesthesia was maintained with 2 fJ!o enflurane at core temperature above 32°C and with I fJ!o enflurane below this temperature. On rewarming analgesia was continued with further doses of fentanyl 10 {tg.kg-I . The bypass prime was 1500 ml of Haemaccel (Behring, Behringwerke AG, Marburg) and 1000 ml of Ringer's solution. On commencing bypass 100 mmol of sodium bicarbonate was given. The arterial carbon dioxide tension was kept as close as possible to 40 mmHg and the pH to 7.4 using an alpha stat pH management. Moderate hypothermia of 25-30°C measured nasopharangeally was used in all patients. Mannitol (0.5 g.kg-I ) was given to all patients after twenty minutes on bypass. Haemoglobin was maintained at greater than 60 g.l-I. The ventilation/perfusion ratio was left at 1.0, unless otherwise suggested by arterial blood gases taken every twenty minutes. If mean arterial pressure fell to less than 50 mmHg, doses of phenylephrine (to a total of 10 mg), metaraminol (to a total of 10 mg) and noradrenaline (to a total of 4 mg) were given. If mean arterial pressure rose to more than 80 mmHg, after excluding inadequate analgesia, further doses of fentanyl, specific vasodilators such as glyceryl trinitrate (to a maximum of 50 mg.hr-I ) and phentolamine (to a total of 10 mg) were given.
A medical perfusionist administered the perfusion in accordance with the following protocol. 1. Fixed flow group. A pump flow of 2.4 l.min -1. m -2 was maintained throughout CPB. 2. Variable flow group. During CPB the flowrate was tailored to the metabolic requirements of the patient as gauged by the SV02 altering the flow from an initial 2.4 l.min -I.m -2 to maintain a SV02 of 75-80010, measured via continuous oximetry (Baxter Bentley® SM0200 oxySAT®meter) of the venous return to the CPB reservoir. The per fusing anaesthetist was able to opt out of the trial at any stage. The two criteria stipulated in the protocol were an increasing metabolic acidosis or the patient having to go back on to CPB.
B. Data collection and analysis
Data collected preoperatively included patient characteristics, the degree of left ventricular impairment, the presence of renal impairment (serum creatinine greater than 120 {tmol.l-I ), hypertension (diastolic blood pressure greater than 110 mmHg), diabetes mellitus, or current therapy involving nonsteroidal anti-inflammatory drugs. The degree of left ventricular impairment was scored from the cardiologist's assessment of depressed contractility on the angiogram (normal =0, mild=l, moderate =2, severe=3). Renal function was measured by frequent serum creatinines (determined by the laffe reaction) and by creatinine clearance levels measured for 24 hours preoperatively and for six hours immediately after termination of CPB.
Information recorded intraoperatively included the doses of all drugs given, mean blood pressures, perfusion pressures, crossclamp time, bypass time, ventilation/perfusion ratios, temperatures and arterial blood gases, Serum creatinines were recorded serially from immediately preoperatively to three days postoperatively.
Statistical analysis was performed using the SAS-PC programme (SAS Institute Inc). Student's t test was used to confirm group comparability with respect to age, sex, height, weight, and degree of hypertension. A Chi-squared test was used to assess group distribution of diabetes, pre-existing renal failure or left ventricular failure. Outcome parameters were analysed using the Wilcoxen rank sum test for the creatinine measurements and analysis of variance for remaining data. Changes in renal and metabolic junction on return to intensive care 
RESULTS
The bypass data is shown in Table 1 . There was a significantly lower flowrate (P < 0.001) in the tailored group (l.3 ±0.2 l.min -I.m -2) than in the fixed flow group (2.4 l.min -I.m -2). A safe perfusion pressure enabling the low flow rate was attained by the use of significantly more vasopressors in the tailored group.
There was no significant difference in the perfusion pressures or the time spent on CPB. The adequacy of perfusion is supported by the lactate and base deficit values taken within one hour of return to the intensive care unit. There is no significant difference between the two groups ( Table 3) .
Sixty patients successfully completed the trial in each group. One patient had to go back onto CPB and one (Jehovah's Witness) died in the intensive care unit postoperatively and these patients were therefore excluded from the trial. The patient characteristics are shown in Table 2 . There were no statistically significant differences between the groups in terms of age, sex, height, weight or in the numbers of patients with preoperatively impaired renal or left ventricular function, hypertension or diabetes mellitus.
The changes in renal and metabolic function are shown in Table 3 . Renal function was assessed by percentage changes in serum creatinines, percentage changes in creatinine clearance and the peak postoperative creatinine. The percentage change in serum creatinine was measured from a sample taken on the preoperative day and one taken within one hour postoperatively. The median percentage change is + 16070 for the fixed flow group with a range of -23070 to + 66070, whilst the median for the variable group is + 20070 with a range of -36070 to + 100070. There is no significant difference between the two groups by either parametric or nonparametric testing. The percentage changes in creatinine clearances were measured from samples taken 24 hours preoperatively and those taken six hours postoperatively. These collections were successfully completed in 48 patients in the variable flow group and 53 patients in the fixed flow group. The median percentage change is + 17070 with a range of -75070 to + 120070 for the fixed flow group and a median of 0070 with a range of -76070 to + 82070 for the variable flow group. Again there is no significant difference in parametric or nonparametric testing. The peak postoperative creatinine was obtained from the highest of daily samples taken for three days post surgery. The median for the fixed flow group is 122 j.tmol.l-I with a range of 86 to 193 versus 125 j.tmol.l-I with a range of 94 to 200 j.tmol.l -I for the variable flows. Again there is no significant difference between these two.
Although the study was designed to compare two techniques of flow management, the data from all 120 patients was taken and retrospectively analysed using multivariate analysis of variance and multiple regression for association with factors thought to be linked with post cardiac surgery renal failure-age, impaired renal and left ventricular function preoperatively, hypertension, diabetes, mean pressure on bypass, aortic crossclamp time and total time spent on CPB. Of these, age and preoperative renal impairment were associated at the 5070 level, and diabetes and mean perfusion pressure on bypass at the 10070 level with the percentage change in serum creatinines.
DISCUSSION
Our findings suggest that whilst a wide variation in effect is seen, a decline in renal function after cardiac surgery is common, with no difference between our two methods of management.
Because of the complex interdependencies of flow, pressure, temperature and drugs used during CPB, optimal conditions are unknown. Some centres avoid low-flow CPB in an attempt to ensure adequate tissue oxygenation, reduce accumulation of acid metabolites, 11 and to preserve renal 4 and cerebral 5 function. The advantages cited by those using low-flow CPB include decrease in trauma to the blood constituents and emboli formation, minimising the bronchial collateral flow to the left ventricle, less tissue oedema and less risk of CPB tubing and connector failures. A potential advantage is improved cerebral outcome. ',7 Excessively low flows, however, are known to increase sympathetic activity postoperatively with raised systemic vascular resistances and raised antidiuretic hormone levels. HIO Few studies have specifically looked at the effect of CPB flows on renal function and ours is the first prospective comparison, to our knowledge, of low with normal flows whilst standardising other aspects of anaesthetic and CPB management.
Previous studies have provided conflicting results on the effect of CPB flows and pressures on subsequent renal function. Koning4 has related low-flow during CPB, patient age and preoperative serum creatinine with increased serum creatinines postoperatively in a retrospective analysis of 130 patients. They did not monitor mixed venous oxygen saturations and on the basis of their nomogram many of our patients should have had a flow of greater than 2 l.min -I.m 2 to attain the same creatinine post-as preoperatively. Yeboah et alii in a retrospective study of 428 open heart operations showed that when perfusion pressure is maintained above 80 mmHg the incidence of renal failure is significantly reduced. Ganesh Bhat et al,12
,lnac5rhe'lia and Infcmil'(, Care, ~o/. 21, .\0. 3, June, 1993 in a retrospective analysis of 490 patients, found no correlation between the occurrence of renal failure and mean arterial pressure and mean flowrate during CPB. The duration of cardiopulmonary bypass was the factor most closely correlated with postoperative renal failure. In particular, low-pressure bypass time was significantly longer in those patients who subsequently developed renal failure. More recently, Urzua et al,13 in a prospective study of 21 patients, showed no postoperative differences in renal function between those patients with untreated arterial blood pressure during CPB (average 57.7 ± 8.2 mmHg) and those who had received vasopressors to maintain their arterial blood pressure above 70 mmHg (average 71.1 ± 3.1).
Abel et ai, 14 in a prospective study of 500 patients, have shown no correlation of acute renal failure postoperatively with lowest and mean blood pressures during the operation or with flowrates on CPB (values not mentioned). Hilberman et ai, 15 in a prospective study of 204 patients, demonstrated the effectiveness of low flow (30-50 ml.kg-I ), low pressure (30-65 mmHg) in preserving postoperative renal function. The definition of postoperative renal failure is not uniform and may be responsible for some of the discrepancies observed in these studies.
The advantage of using mixed venous oxygen saturations to monitor adequacy of CPB was demonstrated by Stanley et al. 16 They showed greater urine outputs, significantly smaller sodium bicarbonate requirements and less pH disturbance when CPB flows were regulated using oxygen tension and saturation measurements than when standard CPB flows (40-60 ml.kg-I.min -I) were used. Whether continuous venous oximetry rather than repeated blood gas estimations should be used routinely during CPB is still a matter of debate. 17, 18 The relationship between venous oxygen tension and lactic acidaemia during CPB has been demonstrated by Swan et al 19 and they advocate frequent monitoring of venous oxygen tension and maintaining it above 35 torr when measured at 37°C.
The overall deterioration in renal function postoperatively is not surprising considering the patient population and the procedure performed. It is presumably due to haemodynamic or toxic insults upon already ischaemic kidneys. Whilst the primary aim of the study was to investigate the effect of flow on renal function, other factors thought to be linked with post cardiac surgery renal failure were investigated taking the data from all 120 patients with the General Linear Models (GLM) procedure of the SAS package. Using mUltiple regression, increasing age (P < 0.02) and lower mean perfusion pressure during bypass (P < 0.09) were predictive of a rise in serum creatinine postoperatively.
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With multiple analysis of variance, preoperative renal impairment (P<O.OOI) and diabetes mellitus (P<0.07) were associated with a rise in serum creatinine postoperatively. These results concur with a number of other studies. 4 ,1I,12,14 Preoperative hypertension, impaired left ventricular function, cardiopulmonary bypass time and aortic crossclamp time did not show a significant relationship to serum creatinine levels postoperatively.
In conclusion, our study confirms others showing that a decline in renal function is common after cardiac surgery but that a wide variation in effect is seen. At the 5070 level there is, however, no significant difference in renal outcome between our groups, and from this point of view CPB flow can safely be lowered using the oxygen saturation of the venous return to gauge metabolic demand, with vasoconstrictors being given to maintain perfusion pressure.
